Lau Associates LLC Has $2.22 Million Stake in Danaher Co. (DHR)

Lau Associates LLC increased its position in Danaher Co. (NYSE:DHR) by 28.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,437 shares of the conglomerate’s stock after purchasing an additional 4,481 shares during the quarter. Danaher accounts for 1.3% of Lau Associates LLC’s portfolio, making the stock its 19th largest position. Lau Associates LLC’s holdings in Danaher were worth $2,221,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the company. Mount Yale Investment Advisors LLC bought a new position in Danaher during the 1st quarter valued at $103,000. IMS Capital Management bought a new position in Danaher during the 2nd quarter valued at $107,000. BerganKDV Wealth Management LLC bought a new position in Danaher during the 2nd quarter valued at $111,000. Fort L.P. bought a new position in Danaher during the 2nd quarter valued at $119,000. Finally, Braun Bostich & Associates Inc. boosted its stake in Danaher by 506.4% during the 2nd quarter. Braun Bostich & Associates Inc. now owns 1,225 shares of the conglomerate’s stock valued at $121,000 after acquiring an additional 1,023 shares during the last quarter. Institutional investors and hedge funds own 76.90% of the company’s stock.

Danaher stock opened at $103.38 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.07 and a current ratio of 1.50. Danaher Co. has a 1 year low of $83.81 and a 1 year high of $110.13. The stock has a market capitalization of $76.04 billion, a PE ratio of 25.65, a price-to-earnings-growth ratio of 2.08 and a beta of 1.01.

Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, July 19th. The conglomerate reported $1.15 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.09 by $0.06. Danaher had a net margin of 13.84% and a return on equity of 11.55%. The business had revenue of $4.98 billion for the quarter, compared to analysts’ expectations of $4.91 billion. During the same quarter last year, the company earned $0.99 EPS. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. On average, research analysts expect that Danaher Co. will post 4.49 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 26th. Investors of record on Friday, September 28th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Thursday, September 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.62%. Danaher’s dividend payout ratio (DPR) is presently 15.88%.

In related news, EVP William K. Daniel sold 103,086 shares of the stock in a transaction dated Friday, August 10th. The shares were sold at an average price of $100.63, for a total value of $10,373,544.18. Following the sale, the executive vice president now owns 167,080 shares of the company’s stock, valued at approximately $16,813,260.40. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 104,913 shares of the stock in a transaction dated Tuesday, July 31st. The stock was sold at an average price of $101.88, for a total transaction of $10,688,536.44. Following the completion of the sale, the insider now directly owns 276,438 shares in the company, valued at approximately $28,163,503.44. The disclosure for this sale can be found here. In the last ninety days, insiders sold 299,961 shares of company stock worth $30,619,691. Corporate insiders own 11.90% of the company’s stock.

A number of research analysts have recently issued reports on DHR shares. Zacks Investment Research downgraded shares of Danaher from a “hold” rating to a “sell” rating in a research report on Wednesday, June 20th. ValuEngine upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research report on Thursday, July 12th. Morgan Stanley raised their price target on shares of Danaher from $122.00 to $126.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Royal Bank of Canada raised their price target on shares of Danaher to $107.00 and gave the stock a “positive” rating in a research report on Thursday, July 19th. They noted that the move was a valuation call. One investment analyst has rated the stock with a hold rating and fifteen have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $111.57.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Featured Story: Analyzing a company’s cash flow statement

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply